A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis

ABSTRACT: A phase 2, double-blind, placebo-controlled trial evaluated apremilast efficacy, safety, and pharmacodynamics in adults with moderate to severe atopic dermatitis (AD).

ORGANISM(S): Homo sapiens

PROVIDER: GSE120899 | GEO | 2018/10/06

REPOSITORIES: GEO